What Cibic Laboratorio does

Cibic Laboratorios is a privately held clinical diagnostic laboratory and biotechnology company headquartered in Rosario, Santa Fe Province, Argentina. The firm operates nine patient care centers across Rosario and Funes and employs approximately 300 professionals, including biochemists, molecular biologists, geneticists, cytogeneticists and flow cytometry specialists working out of CEPIDE, its production, research and development center, and a separate purchasing, storage and logistics hub. Founded in 1991 (per company-history source; firmographics reference cites 1990), the company offers a comprehensive portfolio spanning routine clinical analysis, molecular biology, oncohematology (karyotype, FISH, flow cytometry, PCR, real-time RT-PCR, Sanger sequencing, fragment analysis, NGS), non-invasive prenatal testing (NIPT) with automation, the next-generation ALEX² molecular allergy test, gastrointestinal biomarkers (zonulin, histamine), HPLC-MS urinary metabolites, infectious disease molecular panels including mpox PCR, and rapid syndromic testing via FilmArray (pneumonia and joint panels). The Héritas sub-brand extends the proposition into precision medicine and translational research.

Revenue is generated primarily through Argentine health insurance (obra social) reimbursement and direct patient payments for in-center and home sample collection. A second, higher-margin revenue stream is professional-services B2B testing for referring biochemical laboratories that lack in-house high-complexity capability, served via Extranet and a published Manual de Prestaciones. A third stream is the Argentine distribution of Foundation Medicine (Roche) comprehensive genomic profiling for oncology. Distribution is omnichannel: nine physical centers, home sample collection across Rosario/Funes, WhatsApp virtual attention with extended hours, the MI CIBIC self-serve patient portal/app, and an Extranet for physicians and laboratories. Annual scientific engagement is anchored by the Encuentro Cibic congress (15th edition in October 2024) and the firm's founding-membership role in ALADIL, a Latin American diagnostic laboratories association spanning 14 countries.

The laboratory holds multiple accreditations relevant to its institutional referral channel — FBA (Federación Bioquímica Argentina), ITAES, OAA, IRAM certification including ISO 15189 medical laboratory compliance, and a UN Women WEPs commitment on workplace gender equality (76% women across the team). Strategic technology partnerships include Roche Diagnostics (cobas 5800, Foundation Medicine), SOPHiA GENETICS (DDM myeloid/lymphoid interpretation), AmoyDx (Pan Lung Cancer PCR Panel), and bioMérieux (FilmArray). Geographic operations remain concentrated in Rosario and Funes; ALADIL provides the only documented cross-border institutional footprint.

Name

Cibic Laboratorio

Legal name

Cibic Laboratorios

Website

https://cibic.com.ar

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

251–500 employees

Short description

Cibic Laboratorios is an Argentine clinical diagnostic laboratory in Rosario operating 9 patient care centers. It serves individual patients, physicians, and referring labs with clinical analysis, molecular diagnostics, oncohematology, NIPT, and NGS-based genomic profiling services.

Ownership category

akta.pro rank

Product category

Clinical Diagnostic Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Central Laboratory Services (Core Lab Operations) (HLAGAEAA)

Keywords

• Clinical diagnostic services
• Molecular diagnostics testing
• Oncohematology diagnostics
• Genetic testing laboratory
• Pathology laboratory services

Headquarters

HQ city

Rosario

HQ country

Argentina

HQ region

Latin America

Offices11 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. Clinical Diagnostic Services: Laboratory clinical analysis services provided directly to patients at their 9 care centers and through home sample collection service. Revenue generated through health insurance (obra social) coverage and direct patient payments.
2. Specialized High-Complexity Testing: Advanced diagnostic testing including molecular biology, NGS, cytogenetics, and flow cytometry for hospitals, laboratories, and specialized medical practitioners.
3. Foundation Medicine Distribution: Distribution of Foundation Medicine (Roche) comprehensive genomic profiling tests in Argentina, serving patients, their families, and the medical community.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Core offering

Cibic Laboratorio is a clinical diagnostic laboratory and biotechnology development company that provides routine clinical analysis and high-complexity specialty testing across molecular biology, oncohematology, cytogenetics, and flow cytometry. It serves individual patients through 9 Patient Care Centers in Rosario and Funes, and serves referring laboratories and physicians via specialized high-complexity testing, including distribution of Foundation Medicine (Roche) comprehensive genomic profiling in Argentina.

Product overview

Cibic Laboratorio is a clinical diagnostic laboratory with 35 years of experience offering a comprehensive portfolio of laboratory services. The core offering consists of clinical analysis services, with specialized divisions in Biología Molecular (molecular biology), Oncohematología (oncology/hematology diagnostics), and the sub-brand Héritas for precision medicine. Digital services include MI CIBIC patient portal and Extranet for physicians. Key molecular tests include NIPT prenatal screening, ALEX³ allergy testing, NGS panels for hematological cancers, and real-time PCR panels for lung cancer therapy selection. The laboratory operates 9 patient care centers in Rosario and Funes, supported by CEPIDE (Production, Research and Development Center).

Differentiator

Problem solved

Functional benefit

Brands

• Héritas: Precision medicine and translational research brand operated by Cibic Laboratorios

Products and services

• Análisis Clínicos (Clinical Analysis)
• Oncohematología (Oncohematology)
• Biología Molecular (Molecular Biology)
• Estudio Prenatal No Invasivo (NIPT)
• Test ALEX³ (Allergy Xplorer)
• Foundation Medicine (Roche) Genomic Profiling Distribution
• Panel Mieloide por NGS
• Panel Linfoide por NGS
• Panel Cáncer de Pulmón (11 genes – PCR en tiempo real)
• Plataforma cobas® 5800 System (NAT Blood Donor Screening)
• FilmArray Panel Neumonía
• FilmArray Panel Articular
• Determinación de elastasa pancreática en materia fecal
• Determinación de oxalato y citrato en orina (HPLC-MS)
• Zonulina e histamina (Marcadores gastrointestinales funcionales)
• T3 Reversa (rT3) por quimioluminiscencia
• Panel FISH para Leucemia Mieloide Aguda (AML)
• Extracción a domicilio (Home Sample Collection)
• Certificado COVID para viajes
• MI CIBIC (Patient Portal & Mobile App)
• Extranet (Professional Portal)
• Héritas (Precision Medicine Sub-brand)

Quantifiable outcome

• Reaches 3.5% of Argentina's population through newborn screening programs
• +1 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature10 records

Partnerships

Six partnerships are on record, tiered core, flagship and minor.

• Héritas (Medicina de Precisión)coreStrategic or Co-development PartnerStrategic alliance for translational research and precision medicine. Héritas provides genomic medicine services and the partnership enables comprehensive precision oncology solutions. Joint educational activities include courses on molecular biology applied to medical diagnosis.
• Foundation Medicine (Roche)coreTechnology or IntegrationDistribution partnership for comprehensive genomic profiling tests in Argentina. Foundation Medicine provides advanced cancer genomics testing and Cibic distributes these services to patients, families, and the medical community.
• ALADIL (Asociación de Laboratorios de Diagnósticos Latinoamericanos)flagshipStrategic or Co-development PartnerFounding member of ALADIL, an association connecting diagnostic laboratories across Latin America. Members include laboratories from Ecuador, Peru, Mexico, Honduras, Costa Rica, Uruguay, Dominican Republic, Brazil, Paraguay, Colombia, Venezuela, Guatemala, Chile and Bolivia.
• Círculo Médico de RosariocoreStrategic or Co-development PartnerJoint organization of educational courses including 'Molecular Biology applied to Medical Diagnosis' with Héritas and Círculo Médico de Rosario, conducted online over 10 classes.
• Roche DiagnosticscoreTechnology or IntegrationProvider of cobas® 5800 System fully automated platform and cobas®MPX test for nucleic acid testing (NAT) in blood donor samples.
• Grupo OroñominorStrategic or Co-development PartnerCollaboration in colorectal cancer prevention and early diagnosis initiatives in the framework of World Colon Cancer Day.

Scale indicators5 records

Recent moves8 records

Expansion highlights4 records

Emerging players

• SOPHiA GENETICS: Switzerland-based health technology company providing the SOPHiA DDM analytics platform that Cibic uses for myeloid/lymphoid NGS panels. Comparable as a technology-enabled precision medicine player; also a current vendor/partner with potential to evolve into a competitor as it expands clinical service offerings.

Broad incumbents

• Sonic Healthcare: Global diagnostics operator with multi-country lab networks and significant specialty/esoteric testing capabilities. Comparable as a benchmark for scaled, multi-site specialty diagnostic operators, providing reference valuation and growth trajectory for a private LATAM lab like Cibic.
• Quest Diagnostics: US-headquartered clinical diagnostics leader with broad routine and specialty testing menu including molecular diagnostics and oncology. Comparable as a benchmark for what a scaled, multi-site diagnostic lab looks like, though materially larger and more diversified than Cibic.
• Synlab: Europe's largest clinical diagnostics chain, operating across multiple countries including LATAM. Closest international analog to a multi-center specialty lab model like Cibic, with comparable high-complexity testing menu and B2B referring-laboratory channel.
• Eurofins Scientific: Global leader in bioanalytical testing and clinical diagnostics services across clinical and pharmaceutical markets. Comparable to Cibic on high-complexity clinical testing, specialty panels, and serving referring labs; relevant as a strategic exit/pathway reference for a private specialty lab.
• Laboratory Corporation of America (Labcorp): Global clinical laboratory network offering routine and esoteric diagnostics, with a strong specialty/oncology franchise. Comparable to Cibic as a scaled diagnostic operator with high-complexity capabilities, though US-focused and far larger.

Direct peers

• Laboratorio Stamboulian: Buenos Aires-based Argentine clinical diagnostic laboratory with a strong reputation in infectious disease, molecular biology, and high-complexity testing. Competes with Cibic for referring physicians and is a benchmark specialty lab in the Argentine market.
• Diagnóstico Maipú: One of Argentina's largest private clinical diagnostic laboratory networks with comparable high-complexity testing, multi-center footprint, and physician-targeted service model. Directly competes with Cibic in routine and specialized diagnostics, particularly in routine chemistry and imaging-adjacent testing.

Regional players

• Wiener Lab: Argentine in-vitro diagnostics manufacturer and lab services provider with strong presence across LATAM. Comparable to Cibic as a regional Argentine diagnostics player with a broader product/reagent portfolio and overlapping customer base of clinical laboratories.

Others

• Foundation Medicine (Roche): Roche-owned comprehensive genomic profiling service whose tests Cibic distributes in Argentina. Not a direct competitor but a strategic upstream partner whose relationship and brand Cibic leverages; relevant for understanding Cibic's oncology positioning and concentration risk on Roche.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/CibicLaboratorios

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cibic Laboratorio